Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAtalar, Banu
dc.contributor.authorOzsahin, Mahmut
dc.contributor.authorCall, Jason
dc.contributor.authorNapieralska, Aleksandra
dc.contributor.authorKamer, Serra
dc.contributor.authorVilla, Salvador
dc.contributor.authorErpolat, Petek
dc.contributor.authorNegretti, Laura
dc.contributor.authorLassen\\-Ramshad, Yasmin
dc.contributor.authorOnal, Cem
dc.contributor.authorAkyurek, Serap
dc.contributor.authorUgurluer, Gamze
dc.contributor.authorBaumert, Brigitta G.
dc.contributor.authorServagi\\-Vernat, Stephanie
dc.contributor.authorMiller, Robert C.
dc.contributor.authorOzyar, Enis
dc.contributor.authorSio, Terence T.
dc.date.accessioned2025-10-16T15:25:41Z
dc.date.issued2018
dc.identifier.doi10.1016/j.radonc.2017.12.028
dc.identifier.otherWOS:000433102000015
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8287
dc.publisherELSEVIER IRELAND LTD
dc.sourceRADIOTHERAPY AND ONCOLOGY
dc.subjectAdult medulloblastoma
dc.subjectChemotherapy
dc.subjectCraniospinal
dc.subjectMultimodality
dc.subjectRadiotherapy
dc.subjectRare Cancer Network \\(RCN\\)
dc.titleTreatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS